Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

AUR-AF9A-TTP1-A-1-0-R-A741-41

· D

a853ca65-b68c-5491-aa97-580788faa14d

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
D
subtype
D

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • INTERFERON_ALPHA_RESPONSE+0.430
  • INTERFERON_GAMMA_RESPONSE+0.310
  • WNT_BETA_CATENIN_SIGNALING+0.150
  • SPERMATOGENESIS+0.080
  • KRAS_SIGNALING_DN+0.010
  • G2M_CHECKPOINT-0.010
  • E2F_TARGETS-0.050
  • MITOTIC_SPINDLE-0.050
  • UV_RESPONSE_DN-0.100
  • HEME_METABOLISM-0.110

Top 10 suppressed

  • ANGIOGENESIS-0.580
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.520
  • COAGULATION-0.510
  • MYC_TARGETS_V1-0.480
  • MYC_TARGETS_V2-0.480
  • MTORC1_SIGNALING-0.460
  • ESTROGEN_RESPONSE_EARLY-0.430
  • UNFOLDED_PROTEIN_RESPONSE-0.420
  • CHOLESTEROL_HOMEOSTASIS-0.410
  • HYPOXIA-0.400

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR4195665
colon-landscapes@1
0.890
220040121.LumB
breast-umap@18
D0.886
3SRR650134
bladder-landscape@3
0.866
4TCGA-60-2721-01A-01R-0851-07
lung-landscapes@6
cohortSQ10.860
5SAMN03290914
melanoma-umap@29
0.858
6ERR2208899
melanoma-umap@29
0.854
7SRR23303775
bladder-landscape@3
0.853
8TCGA-P3-A5QE-01A-11R-A28V-07
head-neck@1
0.853
9AUR-AFSP-TTP1-A-8-0-R-A741-41
breast-umap@18
D0.852
10MBCProject_4647_T0_RNA
breast-umap@18
B0.840

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 5 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
INTERFERON_ALPHA_RESPONSE0.430Inavolisib— uncovered
INTERFERON_GAMMA_RESPONSE0.310Idelalisib— uncovered
WNT_BETA_CATENIN_SIGNALING0.150Inavolisib— uncovered
SPERMATOGENESIS0.080Inavolisib— uncovered
KRAS_SIGNALING_DN0.010Remibrutinib— uncovered